Twitxy Saved

JTH

@JTHjournal

JTH will no longer have an active presence on X. While this account will remain available as an archive, we will no longer monitor comments or post new content.
jth.isth.org Joined November 2016
6.8K Following 9.4K Followers 7.7K Posts

Latest posts 5

JTH @JTHjournal
This study provides new insights into VWF regulation in complement-mediated diseases, opening avenues for targeted therapies in TMA and atypical HUS!

✅ W1183R-CFH enhances VWF cleavage by ADAMTS-13, potentially reducing large prothrombotic multimers
✅ Identifies strong binding interactions between CFH and VWF fragments, influencing VWF structural changes
✅ Biophysical and computational modeling demonstrated mechanically induced conformational shifts in the VWF-A2 domain, making it more susceptible to cleavage

@DrXLongZheng

jthjournal.org/article/S1538-…
JTH @JTHjournal
🔍 What are the key design and feasibility challenges in pediatric DOAC trials, and how can future antithrombotic studies be improved to ensure robust and clinically meaningful results?

This Study
✅ Identifies common feasibility barriers, such as sample size adjustments and mismatched clinical populations
✅ Highlights the need for adaptive trial designs to better reflect real-world pediatric VTE management
✅ Stresses the importance of clinically meaningful endpoints and early clinician involvement in trial design

jthjournal.org/article/S1538-…
JTH @JTHjournal
🔍 How can we accurately measure FVIII activity in hemophilia A patients receiving efanesoctocog, particularly in those also on long-term emicizumab therapy?

✅ Efanesoctocog, an ultra-extended half-life FVIII, can now be accurately measured even with emicizumab present
✅ Standard chromogenic assays (CSA) overestimate FVIII—but specific calibration with bovine reagents provides precise results
✅ Low inter-lab variability ensures consistent and reliable testing across centers

🔗jthjournal.org/article/S1538-…
0 replies 6 reposts 19 likes 1.5K views View on X